Cutler Group LP Co Diagnostics, Inc. Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.32 - $3.68 $20,072 - $31,839	-8,652 Reduced 98.35%	145 $0
Q3 2022 Oct 25, 2022	SELL	$2.87 - $7.01 $2,870 - $7,010	-1,000 Reduced 10.21%	8,797 $28,000
Q2 2022 Aug 04, 2022	BUY	$3.76 - $6.29 $31,798 - $53,194	8,457 Added 631.12%	9,797 $54,000
Q1 2022 Apr 14, 2022	BUY	$5.03 - $9.61 $6,036 - $11,532	1,200 Added 857.14%	1,340 $8,000
Q4 2021 Jan 18, 2022	SELL	$8.12 - $10.37 $7,194 - $9,187	-886 Reduced 86.35%	140 $1,000
Q3 2021 Oct 26, 2021	BUY	$7.48 - $11.38 $942 - $1,433	126 Added 14.0%	1,026 $9,000
Q2 2021 Jul 19, 2021	SELL	$7.16 - $9.56 $1,747 - $2,332	-244 Reduced 21.33%	900 $7,000
Q1 2021 Apr 26, 2021	SELL	$8.52 - $19.21 $3,885 - $8,759	-456 Reduced 28.5%	1,144 $10,000
Q4 2020 Jan 21, 2021	SELL	$9.3 - $15.19 $7,440 - $12,152	-800 Reduced 33.33%	1,600 $14,000
Q3 2020 Oct 27, 2020	SELL	$8.24 - $30.8 $34,467 - $128,836	-4,183 Reduced 63.54%	2,400 $32,000
Q2 2020 Jul 22, 2020	BUY	$7.46 - $23.42 $4,401 - $13,817	590 Added 9.84%	6,583 $127,000
Q1 2020 May 07, 2020	BUY	$0.91 - $17.81 $5,453 - $106,735	5,993 New	5,993 $45,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.